Novaryn B17 / About
Quality, Sourcing & Manufacturing
Novaryn B17 is built on a commitment to pharmaceutical-grade quality at every stage — from raw material selection to final formulation.
01 / Brand Philosophy
Not a supplement brand. A clinical biochemical product line.
Novaryn B17 was developed with a singular premise: that Amygdalin deserves to be formulated, positioned, and delivered with the same rigor applied to pharmaceutical-grade compounds. The supplement market has long treated Amygdalin as a commodity. We treat it as a precision biochemical with a complex mechanism, specific formulation requirements, and a practitioner-level audience.
Every decision in the Novaryn B17 product line — from raw material sourcing to capsule formulation to injectable sterility standards — reflects this philosophy. We do not compromise on quality because our audience does not compromise on standards.
02 / Quality Standards
Four Pillars of Novaryn B17 Quality
Sourcing Integrity
Amygdalin is derived exclusively from standardized Prunus armeniaca (apricot) kernel extract, selected for consistent alkaloid profile and minimal contaminant load. Raw materials are sourced from verified suppliers with documented quality certifications. Each batch of raw material undergoes identity verification and purity assessment before processing.
Manufacturing Controls
All Novaryn B17 formulations are produced under GMP-aligned manufacturing conditions. Production processes are documented, controlled, and subject to in-process quality checks. Injectable formulations are manufactured under aseptic conditions with sterility testing, endotoxin testing, and particulate matter inspection for each batch.
Molecular Integrity
Amygdalin is a structurally complex glycoside that can degrade under improper processing conditions. Novaryn B17 formulations are optimized to preserve the active molecular structure through processing, encapsulation, and packaging. Stability studies inform storage recommendations and shelf-life determinations.
Batch Consistency
Each production batch is characterized for Amygdalin content, purity, and physical parameters. Certificate of Analysis documentation is maintained for every batch. This ensures that the product you receive today delivers the same profile as the product you received previously — a standard that matters in precision protocols.
03 / Injectable Standards
Injectable Formulation: Clinical-Grade Standards
The Novaryn B17 injectable line is held to standards that exceed typical supplement manufacturing requirements. Given the clinical application context of injectable formulations, we apply pharmaceutical-grade criteria across the following parameters:
Sterility
Each batch undergoes sterility testing per pharmacopeial standards. Aseptic manufacturing environment with controlled air quality and personnel protocols.
Endotoxin Control
Bacterial endotoxin testing (BET) performed on each batch to ensure pyrogen-free status, critical for injectable safety.
Particulate Matter
Visual inspection and sub-visible particulate testing conducted on each vial batch.
pH & Tonicity
Formulated to physiologically compatible pH range with sodium chloride adjustment for isotonicity.
Container Integrity
Crimp-sealed glass vials with integrity testing. Single-use format to eliminate contamination risk.